Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: Results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 20, Issue 6, 2013, Pages 590-600

  Satoi, Sohei ^a   Yamaue, Hiroki ^b   Kato, Kentaro ^c   Takahashi, Shinichiro ^d   Hirono, Seiko ^b   Takeda, Shin ^e   Eguchi, Hidetoshi ^f   Sho, Masayuki ^g   Wada, Keita ^h   Shinchi, Hiroyuki ⁱ   Kwon, A Hon ^a   Hirano, Satoshi ^c   Kinoshita, Taira ^d   Nakao, Akimasa ^e   Nagano, Hiroaki ^f   Nakajima, Yoshiyuki ^g   Sano, Keiji ^h   Miyazaki, Masaru ^j   Takada, Tadahiro ^k  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NARA MEDICAL UNIVERSITY   (Japan)

^h TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ KAGOSHIMA UNIVERSITY   (Japan)

^j CHIBA UNIVERSITY   (Japan)

^k Japanese Society of Pancreatic Surgery   (Japan)

more..

Author keywords

Adjuvant surgery; Chemotherapy; Radiotherapy; Super responder; Unresectable pancreatic cancer

Indexed keywords

GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE COMPARISON; FEMALE; HUMAN; INOPERABLE CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PANCREAS CANCER; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TIME TO TREATMENT; TREATMENT DURATION; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; BILIARY TRACT SURGERY; CANCER STAGING; CLINICAL TRIAL; EPIDEMIOLOGY; FOLLOW UP; JAPAN; MEDICAL SOCIETY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; SURVIVAL RATE; TIME FACTOR; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BILIARY TRACT SURGICAL PROCEDURES; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; SURVIVAL RATE; TIME FACTORS;

EID: 84881475358     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-013-0616-0     Document Type: Article

References (29)

1. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med. 1992;326:455-65.
2. Conlon KC, Klimstra DS, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathological analysis of 5-year survivors. Ann Surg. 1996;223:273-9.
3. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst. 1988;80:751-5.
4. Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg. 1979;189:205-8.
5. Chauffert B, Mornex F, Bonnetain F, Rougier P, Mariette C, Bouché O, et al. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Ann Oncol. 2008;19:1592-9.
6. Loehrer PJ, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D, et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol. 2011;29:4105-12.
7. Morganti AG, Massaccesi M, La Torre G, Caravatta L, Piscopo A, Tambaro R, et al. A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. Ann Surg Oncol. 2010;17:194-205.
8. Kato K, Kondo S, Hirano S, Tanaka E, Shichinohe T, Tsuchikawa T, et al. Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy. J Hepatobiliary Pancreat Sci. 2011;18:712-6.
9. Ammori JB, Colletti LM, Zalupski MM, Eckhauser FE, Greenson JK, Dimick J, et al. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. J Gastrointest Surg. 2003;7:766-72.
10. Aristu J, Cañón R, Pardo F, Martínez-Monge R, Martin-Algarra S, Manuel Ordoñez J, et al. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am J Clin Oncol 2003;26:30-6.
11. Sa Cunha A, Rault A, Laurent C, Adhoute X, Vendrely V, Béllannée G, et al. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J Am Coll Surg 2005;201:359-65.
12. Gillen S, Schuster T, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7:e1000267.
13. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-16.
14. Evans DB, Rich TA, Byrd DR. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127:1335-9.
15. Sobin L, Gospodarowicz MK, Wittekind C, eds. UICC TNM Classification of Malignant Tumors, 7th ed. New York: Wiley-Liss; 2009.
16. Newgard CD, Hedges JR, Arthur M, Mullins RJ. Advanced statisics: the propensity score - a method for estimating treatment effect in observational research. Acad Emerg Med. 2004;11:953-61.
17. White RR, Hurwitz HI, Morse MA, Lee C, Anscher MS, Paulson EK, et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol. 2001;8:758-65.
18. Marti JL, Hochster HS, Hiotis SP, Donahue B, Ryan T, Newman E. Phase I/II trial of induction chemotherapy followed by concurrent chemoradiotherapy and surgery for locoregionally advanced pancreatic cancer. Ann Surg Oncol. 2008;15:3521-31.
19. Adhoute X, Smith D, Vendrely V, Rault A, Sa Cunha A, Legoux JL, et al. Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapy. Gastroenterol Clin Biol. 2006;30:224-30.
20. Wilkowski R, Thoma M, Schauer R, Wagner A, Heinemann V. Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer. World J Surg. 2004;28:1011-8.
21. Massucco P, Capussotti L, Magnino A, Sperti E, Gatti M, Muratore A, et al. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Ann Surg Oncol. 2006;13:1201-8.
22. Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, et al. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg. 2000;135:81-7.
23. Andriulli A, Festa V, Botteri E, Valvano MR, Koch M, Bassi C, et al. Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. Ann Surg Oncol. 2012;19:1644-62.
24. Bickenbach KA, Gonen M, Tang LH, O'Reilly E, Goodman K, Brennan MF, et al. Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Ann Surg Oncol. 2012;19:1663-9.
25. Donahue TR, Isacoff WH, Hines OJ, Tomlinson JS, Farrell JJ, Bhat YM, et al. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors. Influence on patient selection for surgery. Arch Surg. 2011;146:836-43.
26. Bockhorn M, Burdelski C, Bogoevski D, Sgourakis G, Yekebas EF, Izbicki JR. Arterial en bloc resection for pancreatic carcinoma. Br J Surg. 2011;98:86-92.
27. Amano H, Miura F, Toyota N, Wada K, Katoh K, Hayano K, et al. Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer? J Hepatobiliary Pancreat Surg. 2009;16:850-7.
28. Laurence JM, Tran PD, Morarji K, Eslick GD, Lam VWT, Sandroussi C. A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. J Gastrointest Surg. 2011;15:2059-69.
29. Nakao A, Kanzaki A, Fujii T, Kodera Y, Yamada S, Sugimoto H, et al. Correlation between radiographic classification and pathologic grade of portal vein wall invasion in pancreatic head cancer. Ann Surg. 2012;255:103-8.